The prevalence and determinants of unmet healthcare needs in Bulgaria.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2024
Historique:
received: 01 08 2024
accepted: 08 10 2024
medline: 29 10 2024
pubmed: 29 10 2024
entrez: 29 10 2024
Statut: epublish

Résumé

Self-reported unmet healthcare needs are a useful indicator of access to healthcare, but there is little research from low- and middle-income countries. This study sought to investigate the prevalence and determinants of unmet needs arising from wait times, distance/transportation and financial affordability in Bulgaria using European Health Interview Survey data. We explored associations between individual characteristics and the probability of reporting unmet need by fitting logistic regression models to the data. Unaffordability-related unmet needs were the most cited barrier to access. The largest proportion of people reported unmet dental care needs (14%) or unmet needs due to unaffordability of medicines (8%); distance/transportation problems were the least cited reason (3%). People with poor physical and mental health had a substantially higher probability of experiencing unmet needs. Those with a disability, less disposable income, less social support and lower educational attainment were also more likely to report unmet healthcare needs. People who lived in rural areas experienced specific barriers to access, most notably from distance or transportation issues. Unmet healthcare needs lead to inefficiencies for the healthcare system and are more prevalent among already disadvantaged societal groups. Ensuring better access to healthcare is therefore important from both the efficiency and equity perspectives.

Identifiants

pubmed: 39471180
doi: 10.1371/journal.pone.0312475
pii: PONE-D-24-32036
pmc: PMC11521248
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0312475

Informations de copyright

Copyright: © 2024 Maslyankov, Hernández. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Int J Health Serv. 2013;43(3):567-85
pubmed: 24066422
Int J Health Econ Manag. 2020 Mar;20(1):79-98
pubmed: 31297726
Health Econ Policy Law. 2021 Oct;16(4):400-423
pubmed: 32807251
J Gen Intern Med. 2005 Feb;20(2):148-54
pubmed: 15836548
BMC Oral Health. 2022 Mar 9;22(1):65
pubmed: 35260137
BMJ Open. 2021 Aug 3;11(8):e048860
pubmed: 34344682
Eur J Health Econ. 2015 Sep;16(7):781-96
pubmed: 25186072
Womens Health Issues. 2016 Jan-Feb;26(1):74-9
pubmed: 26384547
Health Policy. 2021 Mar;125(3):341-350
pubmed: 33431257
Health Policy. 2004 Jun;68(3):333-44
pubmed: 15113644
Eur J Ageing. 2023 Apr 29;20(1):12
pubmed: 37119316
J Prev Med Public Health. 2019 Jan;52(1):51-59
pubmed: 30742761
Int J Environ Res Public Health. 2013 May 17;10(5):2017-27
pubmed: 23685827
Am J Public Health. 1997 Mar;87(3):365-70
pubmed: 9096535
Healthcare (Basel). 2022 Jan 30;10(2):
pubmed: 35206888
Health Econ. 2019 Apr;28(4):529-542
pubmed: 30693596
J Health Soc Behav. 1997 Mar;38(1):21-37
pubmed: 9097506
Health Serv Res. 1974 Fall;9(3):208-20
pubmed: 4436074
Health Serv Res. 2006 Jun;41(3 Pt 1):788-803
pubmed: 16704512
Front Public Health. 2021 Jul 02;9:675277
pubmed: 34277542
Soc Sci Med. 2010 Feb;70(3):465-472
pubmed: 19914759
Eur J Public Health. 2014 Oct;24(5):808-13
pubmed: 24287029
J Health Soc Behav. 1995 Mar;36(1):1-10
pubmed: 7738325
Health Policy. 2009 Jun;91(1):24-32
pubmed: 19070930
Healthc Policy. 2009 Aug;5(1):87-101
pubmed: 20676253
Int J Equity Health. 2016 Mar 05;15:41
pubmed: 26944542
J Adolesc Health. 2011 Nov;49(5):490-7
pubmed: 22018563
Front Public Health. 2023 Jun 15;11:1082517
pubmed: 37397766
Eur J Public Health. 2017 Feb 1;27(suppl_1):82-89
pubmed: 28355635
Am J Public Health. 2004 May;94(5):783-9
pubmed: 15117701
Scand J Public Health. 2020 May;48(3):267-274
pubmed: 31405329
Int J Equity Health. 2013 Mar 11;12:18
pubmed: 23496984
Health Econ Policy Law. 2020 Oct;15(4):440-457
pubmed: 31018874
Am J Public Health. 2009 Sep;99(9):1659-65
pubmed: 19608942
BMJ Open. 2017 Sep 11;7(8):e016614
pubmed: 28893735
Health Econ. 2019 Jun;28(6):727-735
pubmed: 31020778
Eur J Public Health. 2016 Oct;26(5):737-742
pubmed: 26936081
Int J Health Serv. 1976;6(3):417-30
pubmed: 955751
Health Policy. 2011 Oct;102(2-3):263-9
pubmed: 21216021
Open Med. 2013 Feb 26;7(1):e21-30
pubmed: 23687534
Health Syst Transit. 2018 Sep;20(4):1-230
pubmed: 30277214
Int J Health Geogr. 2013 May 12;12:27
pubmed: 23663530
J Health Serv Res Policy. 2002 Jul;7(3):186-8
pubmed: 12171751

Auteurs

Ivan Maslyankov (I)

School of Medicine and Population Health, University of Sheffield, Sheffield, United Kingdom.

Mónica Hernández (M)

School of Medicine and Population Health, University of Sheffield, Sheffield, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH